Live from ASCO 2026: Insights on the Latest in Multiple Myeloma, Prostate and Lung Cancer Research
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Live from ASCO 2026: Insights on the Latest in Multiple Myeloma, Prostate and Lung Cancer Research
-
ナレーター：
-
著者：
Alan Bryce, M.D., Chief Clinical Officer, City of Hope Cancer Center Phoenix, discusses promising prostate cancer research that may help doctors treat some patients earlier and more effectively. He explains how a new combination approach around the time of surgery could help keep cancer from spreading and open the door to more treatment options.
Kristin Higgins, M.D., Chief Clinical Officer, City of Hope Cancer Center Atlanta highlights encouraging progress in lung cancer driven by treatments tailored to specific genetic changes. She also discusses an important challenge: some people who develop lung cancer may not fit the profile current screening programs are built to catch.
Joseph Mikhael, M.D., Professor in Clinical Genomics and Therapeutics Division at TGen, explores how quickly treatment is evolving in multiple myeloma. He shares why newer immune-based therapies are generating excitement and how simpler approaches now in development could make advanced treatment more accessible. For him, the pace of change means new options are reaching patients faster than ever.